Llwytho...
Zielgerichtete Therapie beim metastasierten Mammakarzinom – welche molekularen Tests sind notwendig?
In recent years, targeted therapy for breast cancer has received increasingly more attention. In addition to hormone receptors and human epidermal growth factor 2 (HER2), the immunohistochemical detection of programmed cell death ligand 1 (PD-L1) in advanced triple-negative breast cancer and the det...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Gynakol Endokrinol |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer Vienna
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7264922/ https://ncbi.nlm.nih.gov/pubmed/32837693 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s41974-020-00141-z |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|